Centerpoint Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,390
| Closed | -$10K | – | 627 |
|
|
2022
Q4 | $10K | Hold |
3,390
| – | – | ﹤0.01% | 305 |
|
|
2022
Q3 | $14K | Hold |
3,390
| – | – | 0.01% | 203 |
|
|
2022
Q2 | $14K | Hold |
3,390
| – | – | 0.01% | 210 |
|
|
2022
Q1 | $17K | Hold |
3,390
| – | – | 0.01% | 202 |
|
|
2021
Q4 | $24K | Buy |
3,390
+1,000
| +42% | +$7.08K | 0.01% | 170 |
|
|
2021
Q3 | $24K | Hold |
2,390
| – | – | 0.01% | 159 |
|
|
2021
Q2 | $34K | Buy |
2,390
+1,140
| +91% | +$16.2K | 0.02% | 144 |
|
|
2021
Q1 | $21K | Hold |
1,250
| – | – | 0.01% | 134 |
|
|
2020
Q4 | $26K | Hold |
1,250
| – | – | 0.02% | 124 |
|
|
2020
Q3 | $10K | Hold |
1,250
| – | – | 0.01% | 149 |
|
|
2020
Q2 | $10K | Hold |
1,250
| – | – | 0.01% | 158 |
|
|
2020
Q1 | $6K | Sell |
1,250
-1,268
| -50% | -$6.09K | 0.01% | 166 |
|
|
2019
Q4 | $10K | Hold |
2,518
| – | – | 0.01% | 168 |
|
|
2019
Q3 | $8K | Hold |
2,518
| – | – | 0.01% | 171 |
|
|
2019
Q2 | $11K | Buy |
+2,518
| New | +$11K | 0.01% | 158 |
|